FinancialGovernment SolutionsLegalReuters News AgencyRisk Management SolutionsTax & AccountingBlog: Answers OnInnovation @ Thomson Reuters
Directory of sites
Login
Contact
Support
Top News
Detained in Myanmar
North Korea
Reuters Investigates
Tech
The Wider Image
The Road to Brexit
Syria
Sports
Commentary
Pictures
Regulatory News
April 17, 2018 / 12:07 PM / 8 days ago

BRIEF-Highmark Inc Signs Outcomes-Based Agreement With Astrazeneca For Symbicort

Reuters Staff

1 Min Read

April 17 (Reuters) - AstraZeneca PLC:

* HIGHMARK INC. SIGNS OUTCOMES-BASED AGREEMENT WITH ASTRAZENECA FOR SYMBICORT Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.